Logo image of GWAV

GREENWAVE TECHNOLOGY SOLUTIO (GWAV) Stock Fundamental Analysis

NASDAQ:GWAV - Nasdaq - US57630J4031 - Common Stock - Currency: USD

0.1628  -0.06 (-26.4%)

After market: 0.1596 0 (-1.97%)

Fundamental Rating

2

GWAV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of GWAV have multiple concerns. GWAV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

GWAV had negative earnings in the past year.
GWAV had a negative operating cash flow in the past year.
GWAV had negative earnings in 4 of the past 5 years.
In the past 5 years GWAV always reported negative operating cash flow.
GWAV Yearly Net Income VS EBIT VS OCF VS FCFGWAV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

GWAV has a worse Return On Assets (-123.92%) than 95.18% of its industry peers.
With a Return On Equity value of -168.15%, GWAV is not doing good in the industry: 85.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -123.92%
ROE -168.15%
ROIC N/A
ROA(3y)-73.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GWAV Yearly ROA, ROE, ROICGWAV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20K -40K -60K -80K -100K

1.3 Margins

The Gross Margin of GWAV (37.21%) is better than 62.65% of its industry peers.
In the last couple of years the Gross Margin of GWAV has declined.
The Profit Margin and Operating Margin are not available for GWAV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.95%
GM growth 5Y-16.49%
GWAV Yearly Profit, Operating, Gross MarginsGWAV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200K -400K -600K -800K -1M

3

2. Health

2.1 Basic Checks

GWAV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GWAV has been reduced compared to 1 year ago.
GWAV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, GWAV has a worse debt to assets ratio.
GWAV Yearly Shares OutstandingGWAV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
GWAV Yearly Total Debt VS Total AssetsGWAV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

GWAV has an Altman-Z score of -9.54. This is a bad value and indicates that GWAV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of GWAV (-9.54) is worse than 91.57% of its industry peers.
GWAV has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GWAV (0.09) is better than 74.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -9.54
ROIC/WACCN/A
WACC6.72%
GWAV Yearly LT Debt VS Equity VS FCFGWAV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

2.3 Liquidity

GWAV has a Current Ratio of 1.52. This is a normal value and indicates that GWAV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.52, GWAV is in line with its industry, outperforming 45.78% of the companies in the same industry.
A Quick Ratio of 1.36 indicates that GWAV should not have too much problems paying its short term obligations.
GWAV has a Quick ratio of 1.36. This is comparable to the rest of the industry: GWAV outperforms 45.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.36
GWAV Yearly Current Assets VS Current LiabilitesGWAV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

GWAV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.64%.
GWAV shows a small growth in Revenue. In the last year, the Revenue has grown by 3.88%.
Measured over the past years, GWAV shows a very strong growth in Revenue. The Revenue has been growing by 346.94% on average per year.
EPS 1Y (TTM)-8.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.9%
Revenue 1Y (TTM)3.88%
Revenue growth 3Y1427.89%
Revenue growth 5Y346.94%
Sales Q2Q%3.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GWAV Yearly Revenue VS EstimatesGWAV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
GWAV Yearly EPS VS EstimatesGWAV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 -1K -2K -3K -4K -5K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GWAV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GWAV Price Earnings VS Forward Price EarningsGWAV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GWAV Per share dataGWAV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200 -250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GWAV!.
Industry RankSector Rank
Dividend Yield N/A

GREENWAVE TECHNOLOGY SOLUTIO

NASDAQ:GWAV (4/17/2025, 10:37:10 PM)

After market: 0.1596 0 (-1.97%)

0.1628

-0.06 (-26.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-14 2025-04-14
Earnings (Next)05-19 2025-05-19
Inst Owners0.51%
Inst Owner Change0%
Ins Owners5.19%
Ins Owner Change47.08%
Market Cap9.90M
AnalystsN/A
Price TargetN/A
Short Float %6.99%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 0.19
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-286.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.56
BVpS0.84
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -123.92%
ROE -168.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.21%
FCFM N/A
ROA(3y)-73.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.95%
GM growth 5Y-16.49%
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.86%
Cap/Sales 30.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.36
Altman-Z -9.54
F-Score3
WACC6.72%
ROIC/WACCN/A
Cap/Depr(3y)243.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.88%
Revenue growth 3Y1427.89%
Revenue growth 5Y346.94%
Sales Q2Q%3.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-202.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-235.79%
OCF growth 3YN/A
OCF growth 5YN/A